Furthermore, the aberrant nuclear localization of E-Cadherin was identified in more aggressive tumors, raising the possibility that E-Cadherin mislocalization may be linked to tumor progression through EMT-like mechanisms [23]. This evidence concerns the gene CDH1 and neoplasm.